Finance

Lists
Why is 3378 down 3,02%?
Dive Deeper
3378:HKG
Hanx Biopharmaceuticals (Wuhan) Co Ltd
27,02 HKD
-3,02%
(-0,84) 1D
16-окт., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3378...
Open
27,92 HKD
High
27,98 HKD
Low
27,02 HKD
Mkt. cap
3,62 млд
Avg. vol.
8,22 миң
Volume
3,70 миң
52-wk high
33,80 HKD
52-wk low
13,48 HKD
Shares outstanding
136,22 млн
No. of employees
60
Open
27,92 HKD
High
27,98 HKD
Low
27,02 HKD
Mkt. cap
3,62 млд
Avg. vol.
8,22 миң
Volume
3,70 миң
52-wk high
33,80 HKD
52-wk low
13,48 HKD
Shares outstanding
136,22 млн
No. of employees
60
News stories
From web sources and news partners
About Hanx Biopharmaceuticals (Wuhan) Co Ltd
CEO-
Employees60
Founded2014
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. мар.
2025-ж. июн.
2026-ж. мар.
2026-ж. июн.
Revenue
12,50 миң
12,50 миң
3,00 миң
3,00 миң
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15,66 млн
15,66 млн
13,05 млн
13,05 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,03 млн
13,03 млн
13,96 млн
13,96 млн
Operating expense
28,66 млн
28,66 млн
26,82 млн
26,82 млн
Total operating expenses
28,66 млн
28,66 млн
26,82 млн
26,82 млн
Operating income
-28,65 млн
-28,65 млн
-26,81 млн
-26,81 млн
Other non operating income
-190,50 миң
-190,50 миң
-8,75 млн
-8,75 млн
EBT including unusual items
-29,00 млн
-29,00 млн
-22,47 млн
-22,47 млн
EBT excluding unusual items
-31,44 млн
-31,44 млн
-33,05 млн
-33,05 млн
Income tax expense
-12,17 млн
-12,17 млн
-5,85 млн
-5,85 млн
Effective tax rate
41,97%
41,97%
26,02%
26,02%
Other operating expenses
-24,50 миң
-24,50 миң
-191,00 миң
-191,00 миң
Net income
-18,22 млн
-18,22 млн
-18,44 млн
-18,44 млн
Net profit margin
-145 760,00%
-145 760,00%
-614 716,67%
-614 716,67%
Earnings per share
-
-
-
-
Interest and investment income
163,50 миң
163,50 миң
3,03 млн
3,03 млн
Interest expense
-2,77 млн
-2,77 млн
-519,50 миң
-519,50 миң
Net interest expenses
-2,60 млн
-2,60 млн
2,51 млн
2,51 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-28,15 млн
-28,15 млн
-26,09 млн
-26,09 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору